Online citations, reference lists, and bibliographies.
← Back to Search

Inhibition Of Anandamide Hydrolysis By The Enantiomers Of Ibuprofen, Ketorolac, And Flurbiprofen.

C. Fowler, U. Janson, R. Johnson, G. Wahlström, A. Stenström, K. Norström, G. Tiger
Published 1999 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
The endogenous cannabimimetic anandamide is hydrolyzed by a fatty acid amide hydrolase to yield arachidonic acid and ethanolamine. In the present study, the regional distribution of the activity and its sensitivity to inhibition by the enantiomers of ibuprofen, ketorolac, and flurbiprofen has been investigated. The rate of [3H]anandamide hydrolysis was found in both 7-week-old and 90-week-old rats to be in the order hippocampus > cerebral cortex > cerebellum > striatum approximately midbrain, with higher rates of hydrolysis for the 7-week-old rats than for the 90-week-old rats. In whole brain (minus cerebellum), the R(-)-enantiomer of ibuprofen was a mixed-type inhibitor of anandamide hydrolysis and was approximately 2-3 times more potent than the S(+)-enantiomer, IC50 values of 230 and 750 microM, respectively, being found. A similar pattern of inhibition of anandamide hydrolysis was seen when intact C6 rat glioma cells were used. Ketorolac inhibited rat brain anandamide hydrolysis, with IC50 values of 50, 440, and 80 microM being found for the R-, S-, and R,S-forms, respectively. The IC50 value for R-flurbiprofen (60 microM) was similar to the IC50 value for the S-enantiomer (50 microM). These data demonstrate that there is no dramatic enantiomeric selectivity of NSAID compounds as inhibitors of fatty acid amide hydrolase enzyme(s) responsible for the hydrolysis of anandamide. The enantiomers of flurbiprofen and R-ketorolac are the most potent NSAID inhibitors of fatty acid amide hydrolase yet reported.
This paper references
Stereoselective Inhibition of Inducible Cyclooxygenase by Chiral Nonsteroidal Antiinflammatory Drugs
A. Carabaza (1996)
Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist.
D. Deutsch (1993)
High-performance liquid chromatographic determination of anandamide amidase activity in rat brain microsomes.
W. Lang (1996)
Synthesis and characterization of diazomethylarachidonyl ketone: an irreversible inhibitor of N-arachidonylethanolamine amidohydrolase.
W. Edgemond (1998)
Arachidonoyl ethanolamide-[1,2-14C] as a substrate for anandamide amidase.
R. Omeir (1995)
Isomeric inversion of ibuprofen (R)-enantiomer in humans.
D. Kaiser (1976)
The direct linear plot. A new graphical procedure for estimating enzyme kinetic parameters.
R. Eisenthal (1974)
J. Glowinski (1966)
Absolute configuration of (-)-5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2-alpha]pyrrole-1-carboxylic acid, the active enantiomer of ketorolac.
A. Guzmán (1986)
Calculation of Inversion Half‐Lives of Aryl Propionic Acid Class Nonsteroidal Antiinflammatory Drugs
D. Kantoci (1996)
Isolation and structure of a brain constituent that binds to the cannabinoid receptor.
W. Devane (1992)
Ibuprofen inhibits the metabolism of the endogenous cannabimimetic agent anandamide.
C. Fowler (1997)
Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain.
C. Hillard (1995)
Anandamide Amidohydrolase Activity in Rat Brain Microsomes
F. Desarnaud (1995)
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
B. Cravatt (1996)
Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases
W. Neupert (1997)
Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship.
C. Fowler (1997)
The effect of food on the bioavailability of ibuprofen and flurbiprofen from sustained release formulations.
A. Pargal (1996)
Inhibitors of arachidonoyl ethanolamide hydrolysis.
B. Koutek (1994)
Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX‐2 inhibitor
D. Riendeau (1997)

This paper is referenced by
Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis
D. Richardson (2008)
Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen
S. Holt (2001)
Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic pain
J. Guindon (2006)
Evaluation of the role of the arachidonic acid cascade in anandamide's in vivo effects in mice.
J. Wiley (2006)
A randomized, double-masked, clinical study of the efficacy of four nonsteroidal anti-inflammatory drugs in pain control after excimer laser photorefractive keratectomy.
M. Vetrugno (2000)
Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors.
Anna Minkkilae (2010)
Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.
S. Holt (2007)
Involvement of Spinal CB 1 Cannabinoid Receptors on the Antinociceptive Effect of Celecoxib in Rat Formalin Test
M. Rezaei (2016)
Effects of COX‐2 inhibition on spinal nociception: the role of endocannabinoids
L. E. Staniaszek (2010)
Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition.
M. Hamza (2009)
Pain management for dentists: the role of ibuprofen.
A. Pozzi (2011)
Identification and characterization of carprofen as a multitarget fatty acid amide hydrolase/cyclooxygenase inhibitor.
Angelo D. Favia (2012)
Endocannabinoid Oxygenation by Cyclooxygenases, Lipoxygenases, and Cytochromes P450: Cross-Talk between the Eicosanoid and Endocannabinoid Signaling Pathways
C. Rouzer (2011)
Inhibition of Endocannabinoid Metabolism by the Metabolites of Ibuprofen and Flurbiprofen
Jessica Karlsson (2014)
Potential of Endocannabinoids to Control Bladder Pain
D. Bjorling (2018)
Chemistry around imidazopyrazine and ibuprofen: discovery of novel fatty acid amide hydrolase (FAAH) inhibitors.
Frédéric De Wael (2010)
Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor
S. Gouveia-Figueira (2015)
Anandamide metabolism by fatty acid amide hydrolase in intact C6 glioma cells. Increased sensitivity to inhibition by ibuprofen and flurbiprofen upon reduction of extra- but not intracellular pH
S. Holt (2003)
Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors
Alessandro Deplano (2019)
Focus on the three key enzymes hydrolysing endocannabinoids as new drug targets.
S. Vandevoorde (2005)
Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain
J. Guindon (2006)
Pharmacological properties of rat brain fatty acid amidohydrolase in different subcellular fractions using palmitoylethanolamide as substrate.
G. Tiger (2000)
The life cycle of the endocannabinoids: formation and inactivation.
S. Alexander (2009)
Targeting the Androgen Receptor by Taxol in Castration-Resistant Prostate Cancer.
Jingting Jiang (2010)
Synergistic antinociceptive effects of anandamide, an endocannabinoid, and nonsteroidal anti-inflammatory drugs in peripheral tissue: a role for endogenous fatty-acid ethanolamides?
J. Guindon (2006)
Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System
J. Mcpartland (2014)
TRPV1, TRPA1, and CB1 in the isolated vagus nerve – Axonal chemosensitivity and control of neuropeptide release
K. Weller (2011)
Fatty acid amide hydrolase - A target for anti-inflammatory therapies?
S. Holt (2005)
NSAIDs: eNdocannabinoid stimulating anti-inflammatory drugs?
C. Fowler (2012)
Identification and characterization of carprofen as a multi-target FAAH / COX inhibitor
Angelo D. Favia (2013)
Chiral 1,3,4-oxadiazol-2-ones as highly selective FAAH inhibitors.
Jayendra Z Patel (2013)
The Role of the Endogenous Cannabinoid System in Peripheral Analgesia
Josée Guindon (2009)
See more
Semantic Scholar Logo Some data provided by SemanticScholar